Nasdaq · CIK 0001807120
DSGN Design Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Sep 10, 2025. Close $11.65 on Oct 9, 2026, +111% from the 52-week low and -27% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
DSGNOct 9, 2026 · close 11.65
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Design Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Arsani William director sell | $3.0M 562,627 shares | -19% | +94% from low-28% from high | |
| 20Weak | Deepa Prasad director sell | $24k 3,806 shares | -16% | - |
Transactions
The last 16 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | Justin D. Gover director | AGrant or award Stock option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Sep 10, 2025 |
| Sep 9, 2025 | Justin D. Gover director | AGrant or award Stock option (right to buy)derivative | +15,833 | $0.00 | $0 | 15,833 | Sep 10, 2025 |
| Aug 13, 2025 | Arsani William director | SOpen-market sale Common Stockindirect: By Logos Global Master Fund LP | -345,000 | $5.25 | $1.8M | 2,655,000 | Aug 14, 2025 |
| Aug 13, 2025 | Arsani William director | SOpen-market sale Common Stockindirect: By Logos Opportunities Fund II LP | -217,627 | $5.25 | $1.1M | 1,000,000 | Aug 14, 2025 |
| Jun 10, 2025 | Heather A. Berger director | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 10, 2025 | Simeon George director, owner | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 10, 2025 | Rodney W Lappe director | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 10, 2025 | Deepa Prasad director | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 10, 2025 | John P. Schmid director | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 10, 2025 | Arsani William director | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| May 1, 2025 | Chris Storgard Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +400,000 | $0.00 | $0 | 400,000 | May 23, 2025 |
| Jan 2, 2025 | Julie Burgess Chief Accounting Officer | AGrant or award Stock option (right to buy)derivative | +135,000 | $0.00 | $0 | 135,000 | Jan 6, 2025 |
| Jan 2, 2025 | Sean Jeffries Chief Operating Officer | AGrant or award Stock option (right to buy)derivative | +260,000 | $0.00 | $0 | 260,000 | Jan 6, 2025 |
| Jan 2, 2025 | Pratik Shah President, CEO and Chairperson | AGrant or award Stock option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Jan 6, 2025 |
| Jan 2, 2025 | Rodney W Lappe director | AGrant or award Stock option (right to buy)derivative | +25,993 | $0.00 | $0 | 25,993 | Jan 6, 2025 |
| Dec 18, 2024 | Deepa Prasad director | SOpen-market sale Common Stock | -3,806 | $6.27 | $24k | 20,000 | Dec 19, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Heather A. Bergerdirector
- Julie BurgessChief Accounting Officer
- Simeon Georgedirector, owner
- Justin D. Goverdirector
- Sean JeffriesChief Operating Officer
- Rodney W Lappedirector
- Deepa Prasaddirector
- John P. Schmiddirector, other
- Pratik ShahPresident, CEO and Chairperson
- Chris StorgardChief Medical Officer
- Arsani Williamdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.